Results 191 to 200 of about 11,219 (248)

Development and External Validation of a Multivariable Model to Predict Early Minimal Symptom Expression Response in Adult Generalized Myasthenia Gravis Patients Treated With Efgartigimod. [PDF]

CNS Neurosci Ther
Yang Y, Liang T, Zhao M, Yang H, Zhao Z, Yu L, Yan L, Li S, Zhang P, Qi G, Yin J, Xu Z, Luo Z.   +12 more
europepmc   +1 more source

Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol. [PDF]

PLoS One
Gutiérrez-Gutiérrez G, Gómez-Ballesteros R, Sotoca J, Ares A, Villaverde R, Reyes V, Armangué T, Salas E, Díaz-Abós P, Rebollo P, Sarmiento M, Escobar I, Maurino J, Querol L.   +13 more
europepmc   +1 more source

Correction to "Efgartigimod for Generalized Myasthenia Gravis: A Multicenter Real-World Cohort Study in China". [PDF]

Ann Clin Transl Neurol
europepmc   +1 more source

Factors associated with early response to efgartigimod in patients with generalized myasthenia gravis: a multicenter retrospective observational study. [PDF]

J Neurol
Zhu W, Chen Y, Tian C, Wang J, Wen X, Lou H, Jiang Y, Di L, Gu S, Wang Y, Wang Y, Lu Y, Wang M, Xu M, Chen H, Zhao Y, Qi G, Da Y.   +17 more
europepmc   +1 more source

Anti-BCMA/CD19 CAR T cell therapy in patients with refractory generalized myasthenia gravis: a single-arm, phase 1 trial. [PDF]

EClinicalMedicine
Zhang Y, Liu D, Zhang Z, Huang X, Cao J, Wang G, Li H, Li S, Zhang S, Zhang W, Chen H, Du X, Wang Z, Yang M, Luo T, Guo X, Ma T, Peng D, Qi G, Zong S, Cui G, Zheng J, Shi M.   +22 more
europepmc   +1 more source

Novel Emergency Medicine Curriculum Utilizing Self-Directed Learning and the Flipped Classroom Method: Neurologic Emergencies Small Group Module [PDF]

, 2019
Bachmann, Daniel, Barrie, Michael, Chu, Alan, Kaide, Colin, King, Andrew, Leung, Cynthia, Malone, Matthew, McGrath, Jillian   +7 more
core  

Discovery of Zilucoplan: A Complement C5 Inhibitor for Treatment of Anti-Acetylcholine Receptor (AChR) Antibody-Positive Generalized Myasthenia Gravis (gMG). [PDF]

J Med Chem
Ye P, Hammer RP, Wang Z, Dhamnaskar K, Hoarty M, Ma Z, Tang GQ, DeMarco SJ, Ricardo A.   +8 more
europepmc   +1 more source

Assessing the Value Contribution of Vyvgart^® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis. [PDF]

Adv Ther
Cortés-Vicente E, Guerrero A, Díaz C, Martínez E, Toja-Camba FJ, Abad MR, Serra JM, Trillo JL, Martín Machín C, Gil A.   +9 more
europepmc   +1 more source

Analysis of Risk Factor for Progression from Ocular Myasthenia Gravis to Generalized Myasthenia Gravis

Journal of Clinical Personalized Medicine
openaire   +1 more source